A Prospective Pilot Study of the Efficacy of Oral Propranolol in Reduction of the Frequency and Severity of Epistaxis in Hereditary Haemorrhagic Telangiectasia
Authors:
- 23 August 2025
- journal article
- Published by Wiley in Clinical Otolaryngology
- Vol. 51 (1) , 159-163
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- The Use of Beta-Blockers in Hereditary Hemorrhagic Telangiectasia-Related Epistaxis: A Systematic ReviewAmerican Journal of Rhinology & Allergy, 2022
- Second International Guidelines for the Diagnosis and Management of Hereditary Hemorrhagic TelangiectasiaAnnals of Internal Medicine, 2020
- Medical Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Meta‐analysisOtolaryngology–Head and Neck Surgery, 2018
- Efficacy and safety of propranolol for epistaxis in hereditary haemorrhagic telangiectasia: retrospective, then prospective study, in a total of 21 patientsClinical Otolaryngology, 2017
- Epistaxis in hereditary hemorrhagic telangiectasia: An evidence based review of surgical managementJournal of Otolaryngology - Head & Neck Surgery, 2016
- The minimal important difference of the epistaxis severity score in hereditary hemorrhagic telangiectasiaThe Laryngoscope, 2015
- The effects of epistaxis on health‐related quality of life in patients with hereditary hemorrhagic telangiectasiaInternational Forum of Allergy & Rhinology, 2014
- A new endoscopic staging system for hereditary hemorrhagic telangiectasiaInternational Forum of Allergy & Rhinology, 2014
- Vascular Endothelial Growth Factor Serum Levels Are Elevated in Patients with Hereditary Hemorrhagic TelangiectasiaActa Haematologica, 2003